Cannacord Genuity analyst note today29 Apr 2026 19:33
CG have published an updated research note today. Their valuation of 181p and continued Buy recommendation is based on a certain amount of “derisking” to reflect the current macro environment. They have revenue increasing marginally to $53.9m and Adj EBITDA moving from $16.4m to $19.4m. They comment that the visibility and quality of revenue is much improved.
“FY27E, we forecast Bango to have two 'Rule of 40' businesses on an adj EBITDA basis. We believe this outcome is not currently reflected in Bango's valuation. We update our target price following the new segmental reporting this morning, and apply our previous target multiples of 10x Payments EBITDA and 3x Subscriptions revenues to our new FY26E segmental forecasts. This generates a new 181p target price, 15% below our previous 212p target (on FY27E, it would be near 200p). We reiterate our Buy rating and our new target price implies a >2x opportunity.”
Reading this - and in the belief that CG’s valuation metrics are fair - you’d have to say the problem is not so much with the company but the market’s appraisal of it.